Currently predicting for Tue, 28 May 2024

Trading levels for VSTM

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 5.69 38.19 %
R2 5.22 26.78 %
R1 4.93 19.74 %
Current price: 4.12
Support S1 3.99 -3.07 %
S2 3.70 -10.12 %
S3 3.23 -21.52 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 4.12
Support S1 0 .
S2 0 .
S3 0 .

VSTM Predictions History

4 years ago
ss predicted that VSTM for 2019-07-02 is going $1.55 (-90.64%)

Rank:

4 years ago
ss predicted that VSTM for 2019-06-24 is going $2.02 (-90.70%)

Rank:

4 years ago
ss predicted that VSTM for 2019-06-19 is going $2.06 (-90.57%)

Rank:

4 years ago
ss predicted that VSTM for 2019-06-18 is going $2.11 (-90.34%)

Rank:

4 years ago
ss predicted that VSTM for 2019-06-17 is going $1.51 (-91.01%)

Rank:

4 years ago
ss predicted that VSTM for 2019-06-14 is going $1.41 (-90.75%)

Rank:

4 years ago
ss predicted that VSTM for 2019-06-06 is going $1.41 (-90.82%)

Rank:

4 years ago
ss predicted that VSTM for 2019-05-30 is going $1.33 (-91.60%)

Rank:

4 years ago
ss predicted that VSTM for 2019-05-28 is going $1.40 (-90.74%)

Rank:

5 years ago
ss predicted that VSTM for 2019-05-21 is going $1.85 (-89.99%)

Rank:
Click to get the best stock tips daily for free!

About Verastem

Verastem Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylate MEK. The company also engages in developing RAMP 201, an adaptive two-part multicenter, parallel coho... VSTM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT